← Evidence map

ArticleTranslational gastroenterology and hepatology2026

Tobevibart plus elebsiran in hepatitis D: crossing a therapeutic threshold.

Javier Crespo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42866838